HNW
GILD icon

High Note Wealth’s Gilead Sciences GILD Stock Holding History

High Note Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21K Hold
65
– – ﹤0.01% 453
2026
Q1 		$9.06K Buy
65
+15
+30% +$2.1K ﹤0.01% 393
2025
Q4 		$6.14K Buy
50
+43
+614% +$5.23K ﹤0.01% 435
2025
Q3 		$777 Buy
7
+3
+75% +$341 ﹤0.01% 747
2025
Q2 		$443 Hold
4
– – ﹤0.01% 770
2025
Q1 		$448 Sell
4
-74
-95% -$7.64K ﹤0.01% 761
2024
Q4 		$7.21K Buy
+78
New +$7.02K ﹤0.01% 339

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

High Note Wealth's GILD Position: Q2 2026 in Review

High Note Wealth held its Gilead Sciences (GILD) position steady in Q2 2026 at 65 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

High Note Wealth first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.06K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • High Note Wealth held 65 shares of Gilead Sciences worth $8.21K as of Q2 2026.
  • High Note Wealth left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #453 holding.
  • High Note Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • High Note Wealth's Gilead Sciences position peaked at $9.06K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.